Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paclitaxel-Based Chemoradiotherapy for Esophageal Cancer
NCT00009880Phase 2Completed
- Sponsor
- NRG Oncology
- Start
- Apr 2001
- Primary completion
- Jul 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of paclitaxel in esophageal carcinoma, gastroesophageal junction adenocarcinoma, sponsored by NRG Oncology. Started Apr 2001; status: completed.
02
Drugs
paclitaxel
03
Conditions
esophageal carcinomagastroesophageal junction adenocarcinoma
Beyond the preview
Go deeper on NCT00009880.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00009880.